Publication | Open Access
OA 17.05 IFCT-1502 CLINIVO: Real-Life Experience with Nivolumab in 600 Patients (Pts) with Advanced Non-Small Cell Lung Cancer (NSCLC)
39
Citations
0
References
2017
Year
MedicineImmune Checkpoint InhibitorReal-life ExperienceCancer TreatmentIfct-1502 ClinivoOncologyRadiation OncologyLung CancerRadiologyHealth Sciences
No additional data available for this publication yet. Check back later!